iRadimed
IRMD
114 hedge funds and large institutions have $271M invested in iRadimed in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 14 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 33
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
2% more funds holding
Funds holding: 112 → 114 (+2)
0.45% less ownership
Funds ownership: 48.68% → 48.23% (-0.45%)
8% less capital invested
Capital invested by funds: $293M → $271M (-$22.2M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.47M |
| 2 |
Millennium Management
New York
|
+$1.48M |
| 3 |
BCC
Bridge City Capital
Lake Oswego,
Oregon
|
+$1.31M |
| 4 |
Swiss National Bank
Zurich,
Switzerland
|
+$771K |
| 5 |
Morgan Stanley
New York
|
+$651K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.76M |
| 2 |
RCG
Resource Consulting Group
Orlando,
Florida
|
-$6.11M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.63M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$980K |
| 5 |
Man Group
London,
United Kingdom
|
-$959K |
IRMD Hedge Fund Activity: Q3 2023 in Review
114 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2023, worth a combined $271M — down 7.6% from $293M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new IRMD positions and 14 closed out — a net gain of 2 holders — while 48 added to existing stakes and 33 trimmed.
The largest buyer was BlackRock, adding an estimated $5.47M. The largest seller was Soleus Capital Management, cutting an estimated $6.76M.
- 114 institutional investors held iRadimed (IRMD) as of Q3 2023, up from 112 in Q2 2023.
- Funds reported $271M of iRadimed stock for Q3 2023, down 7.6% quarter-over-quarter.
- 16 funds opened new iRadimed positions in Q3 2023 and 14 closed out, a net change of +2 holders.
- The largest iRadimed buyer in Q3 2023 was BlackRock, an estimated $5.47M added.
- The largest iRadimed seller in Q3 2023 was Soleus Capital Management, an estimated $6.76M sold.
Based on aggregated 13F filings for Q3 2023.